Present and future projects of the International Breast Cancer Study Group

A. Goldhirsch, R. D. Gelber, M. Castiglione, K. N. Price, C. M. Rudenstam -, J. Lindtner, J. Collins, H. J. Senn, K. W. Brunner, E. Galligioni, F. Cavalli, A. Gudgeon, H. Cortes-Funes, M. Tattersall, G. Marini, M. Byrne, R. Snyder, J. F. Forbes, C. Hurny, A. Coates

Research output: Contribution to journalArticlepeer-review


The International Breast Cancer Study Group (formerly the Ludwig Group) has conducted nine clinical trials since 1978 (see the Appendix for participants and authors). Biologic hypotheses related to the combined use of chemotherapy and endocrine therapy in women with operable breast cancer were tested. Questions of timing of chemotherapy with respect to tumor surgery and late introduction of chemotherapy were also evaluated. On-going and future trials continue in this tradition to investigate combinations of available endocrine therapies and cytotoxic agents.

Original languageEnglish
Pages (from-to)1139-1149
Number of pages11
Issue number3
Publication statusPublished - 1994


  • adjuvant therapy
  • breast cancer
  • chemoendocrine therapy
  • chemotherapy
  • clinical trials
  • cyclophosphamide-methotrexate-5- fluorouracil
  • endocrine therapy
  • tamoxifen

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Present and future projects of the International Breast Cancer Study Group'. Together they form a unique fingerprint.

Cite this